Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1958 1
1983 1
1984 2
1985 4
1986 6
1987 6
1988 7
1989 11
1990 17
1991 20
1992 21
1993 27
1994 21
1995 27
1996 21
1997 20
1998 31
1999 27
2000 39
2001 44
2002 52
2003 48
2004 57
2005 49
2006 46
2007 55
2008 61
2009 56
2010 64
2011 78
2012 50
2013 50
2014 53
2015 64
2016 60
2017 68
2018 71
2019 83
2020 67
2021 66
2022 52
2023 52
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,540 results

Results by year

Filters applied: . Clear all
Page 1
Vaginitis: Diagnosis and Treatment.
Paladine HL, Desai UA. Paladine HL, et al. Am Fam Physician. 2018 Mar 1;97(5):321-329. Am Fam Physician. 2018. PMID: 29671516 Free article. Review.
Vaginitis is defined as any condition with symptoms of abnormal vaginal discharge, odor, irritation, itching, or burning. The most common causes of vaginitis are bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. Bacterial vaginosis is …
Vaginitis is defined as any condition with symptoms of abnormal vaginal discharge, odor, irritation, itching, or burning. The most common ca …
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
van Schalkwyk J, Yudin MH; INFECTIOUS DISEASE COMMITTEE. van Schalkwyk J, et al. J Obstet Gynaecol Can. 2015 Mar;37(3):266-274. doi: 10.1016/S1701-2163(15)30316-9. J Obstet Gynaecol Can. 2015. PMID: 26001874
Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. ...(II-2A) 7. Symptomatic bacterial vaginosis should be treated with oral metronidazole 500 mg twice daily for 7 days. ...
Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies …
Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial.
Chen R, Li R, Qing W, Zhang Y, Zhou Z, Hou Y, Shi Y, Zhou H, Chen M. Chen R, et al. Reprod Health. 2022 Jun 13;19(1):137. doi: 10.1186/s12978-022-01449-z. Reprod Health. 2022. PMID: 35698149 Free PMC article. Review.
BACKGROUND: Bacterial vaginosis (BV) is one of the most common vaginal infectious diseases in female reproductive period. ...Our meta-analysis found that probiotics may play an active role in adjuvant treatment of bacterial vaginosis by conventional an …
BACKGROUND: Bacterial vaginosis (BV) is one of the most common vaginal infectious diseases in female reproductive period. ...O …
Vaginal microbiome transplantation in women with intractable bacterial vaginosis.
Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, Strahilevitz J, Moses AE, Shapiro H, Yagel S, Elinav E. Lev-Sagie A, et al. Nat Med. 2019 Oct;25(10):1500-1504. doi: 10.1038/s41591-019-0600-6. Epub 2019 Oct 7. Nat Med. 2019. PMID: 31591599 Clinical Trial.
One patient presented with incomplete remission in clinical and laboratory features. No adverse effects were observed in any of the five women. Notably, remission in three patients necessitated repeated VMT, including a donor change in one patient, to elicit a long-standin …
One patient presented with incomplete remission in clinical and laboratory features. No adverse effects were observed in any of the f …
Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.
Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, Green L, Miller S, Powell J, Parks T, Hemmerling A. Cohen CR, et al. N Engl J Med. 2020 May 14;382(20):1906-1915. doi: 10.1056/NEJMoa1915254. N Engl J Med. 2020. PMID: 32402161 Free PMC article. Clinical Trial.
BACKGROUND: Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence suggests the need for new treatments to prevent recurrent bacterial vaginosi …
BACKGROUND: Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with …
Bacterial vaginosis.
Levett PN. Levett PN. West Indian Med J. 1989 Sep;38(3):126-32. West Indian Med J. 1989. PMID: 2694618 Review.
Bacterial vaginosis is a common, non-inflammatory infection of the vagina. ...The pathogenesis, laboratory diagnosis, treatment, and the mechanisms by which these organisms produce the symptoms of bacterial vaginosis are discussed....
Bacterial vaginosis is a common, non-inflammatory infection of the vagina. ...The pathogenesis, laboratory diagnosis, treatmen …
Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
Russo R, Karadja E, De Seta F. Russo R, et al. Benef Microbes. 2019 Feb 8;10(1):19-26. doi: 10.3920/BM2018.0075. Epub 2018 Dec 10. Benef Microbes. 2019. PMID: 30525953 Clinical Trial.
Bacterial vaginosis (BV) is the most common cause of vaginal discomfort in women. ...Nowadays, evidence exists about the efficacy of probiotics for the management of BV. The aim of the current double blind, randomised clinical trial was to asses …
Bacterial vaginosis (BV) is the most common cause of vaginal discomfort in women. ...Nowadays, evidence exists about the effic …
Bacterial vaginosis and surgical site infections.
Soper DE. Soper DE. Am J Obstet Gynecol. 2020 Mar;222(3):219-223. doi: 10.1016/j.ajog.2019.09.002. Epub 2019 Sep 6. Am J Obstet Gynecol. 2020. PMID: 31499057 Review.
Bacterial vaginosis is the most common cause of abnormal vaginal discharge or malodor, affecting up to one third of US women. ...The bacterial vaginosis diagnostic criteria are simple and screening tests are inexpensive; bacterial vaginosis …
Bacterial vaginosis is the most common cause of abnormal vaginal discharge or malodor, affecting up to one third of US women. …
Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial.
Mändar R, Sõerunurk G, Štšepetova J, Smidt I, Rööp T, Kõljalg S, Saare M, Ausmees K, Le DD, Jaagura M, Piiskop S, Tamm H, Salumets A. Mändar R, et al. Benef Microbes. 2023 Apr 18;14(2):143-152. doi: 10.3920/BM2022.0091. Epub 2023 Mar 1. Benef Microbes. 2023. PMID: 36856121 Clinical Trial.
Health of reproductive tract is tightly associated with balance of microbial communities in this area. Bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) represent common disturbances of vaginal communities. ...In conclusion, the novel formulations of evide …
Health of reproductive tract is tightly associated with balance of microbial communities in this area. Bacterial vaginosis (BV …
The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy.
Barthow C, Wickens K, Stanley T, Mitchell EA, Maude R, Abels P, Purdie G, Murphy R, Stone P, Kang J, Hood F, Rowden J, Barnes P, Fitzharris P, Craig J, Slykerman RF, Crane J. Barthow C, et al. BMC Pregnancy Childbirth. 2016 Jun 3;16(1):133. doi: 10.1186/s12884-016-0923-y. BMC Pregnancy Childbirth. 2016. PMID: 27255079 Free PMC article. Clinical Trial.
METHODS/DESIGN: The PiP Study is a two-centre, randomised, double-blind placebo-controlled trial in Wellington and Auckland, New Zealand. ...TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registration: ACTRN12612000196842. ...
METHODS/DESIGN: The PiP Study is a two-centre, randomised, double-blind placebo-controlled trial in Wellington and Auckland, N …
1,540 results